DeepHealth
DeepHealth, a wholly-owned subsidiary of RadNet, Inc., is a global leader in AI-powered health informatics focused on radiology. The company develops advanced AI-driven software solutions that enhance diagnostic workflows, operational efficiency, and clinical confidence across the care continuum. Its product portfolio includes Enterprise Imaging solutions like Diagnostic Suite™, Operations Suite™, TechLive™, DeepHealth RIS, and DeepHealth PACS, as well as Population Health solutions such as SmartMammo™, DeepHealth Prostate, DeepHealth Lung, and DeepHealth Brain. DeepHealth leverages a cloud-native operating system, DeepHealth OS, to unify data and personalize AI-powered workspaces. With over 350 customers worldwide, 800+ clinical sites, 3,000+ radiologists, and managing over 20 million imaging studies annually, DeepHealth supports more than 300 AI-powered cancer screening sites in the US and Europe, delivering 1.3 million AI-powered diagnoses per year. The company benefits from RadNet's vertical integration, enabling rapid development and clinical validation of AI solutions, and maintains a strong global presence with local clinical expertise.
DeepHealth
DeepHealth, a wholly-owned subsidiary of RadNet, Inc., is a global leader in AI-powered health informatics focused on radiology. The company develops advanced AI-driven software solutions that enhance diagnostic workflows, operational efficiency, and clinical confidence across the care continuum. Its product portfolio includes Enterprise Imaging solutions like Diagnostic Suite™, Operations Suite™, TechLive™, DeepHealth RIS, and DeepHealth PACS, as well as Population Health solutions such as SmartMammo™, DeepHealth Prostate, DeepHealth Lung, and DeepHealth Brain. DeepHealth leverages a cloud-native operating system, DeepHealth OS, to unify data and personalize AI-powered workspaces. With over 350 customers worldwide, 800+ clinical sites, 3,000+ radiologists, and managing over 20 million imaging studies annually, DeepHealth supports more than 300 AI-powered cancer screening sites in the US and Europe, delivering 1.3 million AI-powered diagnoses per year. The company benefits from RadNet's vertical integration, enabling rapid development and clinical validation of AI solutions, and maintains a strong global presence with local clinical expertise.